Bosh sahifaORINF • OTCMKTS
add
Orion Oyj Class B
Yopilish kursi
82,75 $
Yillik diapazon
78,95 $ - 82,75 $
Bozor kapitalizatsiyasi
9,85 mlrd EUR
Oʻrtacha hajm
3,00
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
HEL
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (EUR) | mar, 2026info | Y/Y qiyosi |
|---|---|---|
Daromad | 417,70 mln | 17,79% |
Joriy xarajat | — | — |
Sof foyda | — | — |
Sof foyda marjasi | 21,64 | 25,16% |
Har bir ulushga tushum | 0,64 | 45,45% |
EBITDA | — | — |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (EUR) | mar, 2026info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | — | — |
Jami aktivlari | — | — |
Jami passivlari | — | — |
Umumiy kapital | — | — |
Tarqatilgan aksiyalar | — | — |
Narxi/balansdagi bahosi | — | — |
Aktivlardan daromad | 14,03% | — |
Kapitaldan daromad | 18,85% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (EUR) | mar, 2026info | Y/Y qiyosi |
|---|---|---|
Sof foyda | — | — |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland.
Orion's class A and B shares are listed on the Helsinki Stock Exchange. Wikipedia
CEO
Tashkil etilgan
21-sen, 1917
Sayt
Xodimlar soni
4 132
